Wave Life Sciences, Inc. (WVE)
NGM · Biotechnology
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Company overview
Wave Life Sciences, Inc., a clinical-stage biotechnology company, focuses on unlocking the potential of ribonucleic acid (RNA) medicines to transform human health. Its RNA medicines platform, PRISM, combines RNA medicine modalities, chemistry innovation, and deep insights in human genetics to deliver scientific breakthroughs that treat rare and common disorders. Its pipeline focuses on obesity (WVE-007), alpha-1 antitrypsin deficiency (AATD) (WVE-006), and PNPLA3 I148M liver disease (WVE-008) programs; and clinical programs for Duchenne muscular dystrophy and Huntington's disease, as well as various preclinical programs utilizing its RNA medicines platform. Wave Life Sciences, Inc. was founded in 2012 and is headquartered in Cambridge, Massachusetts.
Peers in Biotechnology
All in industry →Vertex Pharmaceuticals Incorporated
Regeneron Pharmaceuticals, Inc.
argenx SE
Alnylam Pharmaceuticals, Inc.
BeOne Medicines AG
Insmed Incorporated
Royalty Pharma plc
BioNTech SE
Roivant Sciences Ltd.
Moderna, Inc.
Recent press releases
April 2026
Wave Life Sciences initiates hearing to redomiciliate from Singapore to the US
# 🧾 What This Document Is 📰 This filing is a Form 8-K, which is a mandatory "Current Report" filed with the Securities and Exchange Commission (SEC). Think of it like a real-time bulletin board, used when a company needs to quickly and publicly announce a major, non-routine event to its investors
WVE seeks redomiciliation from Singapore to the United States
# 📄 What This Document Is 📜 This document is an 8-K filing, which is a required public filing that notifies investors and the public about major, unscheduled events that have occurred or are planned by the company. Essentially, it’s a heads-up bulletin about a significant corporate action. 👉 The
SEC filings
All filings →Insider trades
All insider trades →Wave Life Sciences, Inc. has no reported insider trades in the last 90 days.